Related Experiment Video
Updated: May 10, 2026
08:42
A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
Study protocol: a systematic review of pediatric shared decision making
Kirk D Wyatt1, Gabriela Prutsky Lopez, Juan Pablo Domecq Garces
1Knowledge and Evaluation Research (KER) Unit, Mayo Clinic, Rochester, MN 55905, USA.
Systematic Reviews
|July 3, 2013
Summary
This systematic review examines shared decision-making in pediatrics, focusing on interventions and their impact. Due to limited data, a meta-narrative approach will be used to synthesize findings on pediatric shared decision-making.
Area of Science:
- Pediatric Healthcare Research
- Clinical Decision-Making Science
Background:
- Shared decision-making (SDM) in pediatrics involves children, caregivers, and clinicians.
- Patient involvement in SDM is tailored to developmental levels.
- Limited knowledge exists on pediatric-specific SDM interventions and their effectiveness.
Purpose of the Study:
- To systematically review pediatric shared decision-making (SDM) practices, tools, techniques, and technologies.
- To summarize the effects of SDM interventions in pediatric care.
- To identify and analyze methods engaging pediatric patients and caregivers in healthcare decisions.
Main Methods:
- Systematic literature review across multiple databases (MEDLINE, EMBASE, Cochrane, Web of Science, Scopus, PsycInfo).
- Inclusion of original research studies involving patients under 18, caregivers, or both.
- Exclusion of perinatal and research participation decisions; quality assessment performed.
Main Results:
- Anticipated paucity of quantitative data on pediatric SDM interventions.
- Expected heterogeneity in reported results from included studies.
- Potential inability to perform quantitative analysis.
Conclusions:
- A meta-narrative approach is planned due to anticipated data limitations.
- This approach will synthesize findings on pediatric shared decision-making.
- Further research may be needed to address data gaps.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:09Decision Making: P-value Method
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:14Decision Making: Traditional Method
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...